Author Correction: Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
Guardado en:
Autores principales: | Julia A. Yaglom, Yongmei Wang, Amy Li, Zhenghu Li, Stephano Monti, Ilya Alexandrov, Xiongbin Lu, Michael Y. Sherman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c99698d2e6be46d5ae1dcb53cb388aa4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Functional analysis of Hsp70 inhibitors.
por: Rainer Schlecht, et al.
Publicado: (2013) -
HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
por: Toshiki Kijima, et al.
Publicado: (2018) -
Identification of HSP90 inhibitors as a novel class of senolytics
por: Heike Fuhrmann-Stroissnigg, et al.
Publicado: (2017) -
Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90
por: Guohua Zhang, et al.
Publicado: (2017) -
Anti-leukemia activity of a Hsp70 inhibitor and its hybrid molecules
por: Seong-Hyun Park, et al.
Publicado: (2017)